Management Discussion and Analysis For the Annual Operating Results 2018 Ended December 31, 2018 Note: This Management Discussion and Analysis (MD&A) was made to disclose information and the vision
below; Fleet Type As of 30 September 2019 As of 30 September 2018 Airbus A320 9 9 Airbus A319 16 15 ATR 72-500 2 6 ATR 72-600 13 9 Total 40 39 One Airbus A319 under operating lease were delivered in
2018 Airbus A320 9 9 Airbus A319 16 14 ATR 72-500 2 6 ATR 72-600 13 9 Total 40 38 5 ASIA’S BOUTIQUE AIRLINE Two Airbus A319 under operating lease were delivered in July 2018 and January 2019 respectively
) (meaning total expenses from the standalone financial statements net loss on sales of investment, and loss on sales of leasehold right) divided by ASK. CASK – Fuel : The sum of operating cost, sale expenses
. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.029/2019 28 February 2019 Subject : Explanation of the change in operating results for the year 2018
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.064/2018 14 May 2018 Subject : Explanation of the change in operating results of Q1/2018 which exceed
www.bangkokchainhospital.com บริษัท บางกอก เชน ฮอสปิทอล จ ากัด (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.106/2018 8 August 2018 Subject : Explanation of the change in operating results of Q2/2018 which
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.158/2018 12 November 2018 Subject : Explanation of the change in operating results of Q3/2018 which
www.bangkokchainhospital.com บริษัท บางกอก เชน ฮอสปิทอล จ ากัด (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.172/2018 30 November 2018 Subject : Explanation of the change in operating results of Q3/2018 which